Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Payables (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Payables for 6 consecutive years, with $25.6 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Payables fell 35.07% year-over-year to $25.6 million, compared with a TTM value of $25.6 million through Dec 2024, down 35.07%, and an annual FY2024 reading of $25.6 million, down 35.07% over the prior year.
  • Payables was $25.6 million for Q4 2024 at Cresco Labs, down from $39.4 million in the prior quarter.
  • Across five years, Payables topped out at $39.4 million in Q4 2023 and bottomed at $23.2 million in Q4 2020.
  • Average Payables over 5 years is $29.7 million, with a median of $28.1 million recorded in 2022.
  • The sharpest move saw Payables plummeted 63.03% in 2020, then soared 40.26% in 2023.
  • Year by year, Payables stood at $23.2 million in 2020, then surged by 38.94% to $32.3 million in 2021, then dropped by 12.97% to $28.1 million in 2022, then surged by 40.26% to $39.4 million in 2023, then crashed by 35.07% to $25.6 million in 2024.
  • Business Quant data shows Payables for CRLBF at $25.6 million in Q4 2024, $39.4 million in Q4 2023, and $28.1 million in Q4 2022.